Cancer Tumor Profiling- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Table of Contents

1 Market Overview
    1.1 Cancer Tumor Profiling Product Introduction
    1.2 Global Cancer Tumor Profiling Market Size Forecast (2020-2031)
    1.3 Cancer Tumor Profiling Market Trends & Drivers
        1.3.1 Cancer Tumor Profiling Industry Trends
        1.3.2 Cancer Tumor Profiling Market Drivers & Opportunity
        1.3.3 Cancer Tumor Profiling Market Challenges
        1.3.4 Cancer Tumor Profiling Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Cancer Tumor Profiling Players Revenue Ranking (2024)
    2.2 Global Cancer Tumor Profiling Revenue by Company (2020-2025)
    2.3 Key Companies Cancer Tumor Profiling Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Cancer Tumor Profiling Product Offered
    2.5 Key Companies Time to Begin Mass Production of Cancer Tumor Profiling
    2.6 Cancer Tumor Profiling Market Competitive Analysis
        2.6.1 Cancer Tumor Profiling Market Concentration Rate (2020-2025)
        2.6.2 Global 5 and 10 Largest Companies by Cancer Tumor Profiling Revenue in 2024
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2024)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Next-generation Sequencing (NGS)
        3.1.2 Polymerase Chain Reaction (PCR)
        3.1.3 Immunohistochemistry (IHC)
        3.1.4 In Situ Hybridization (ISH)
        3.1.5 Microarray
        3.1.6 Others
    3.2 Global Cancer Tumor Profiling Sales Value by Type
        3.2.1 Global Cancer Tumor Profiling Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Cancer Tumor Profiling Sales Value, by Type (2020-2031)
        3.2.3 Global Cancer Tumor Profiling Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Personalized Medicine
        4.1.2 Diagnostics
        4.1.3 Biomarker Discovery
        4.1.4 Prognostics
        4.1.5 Research Applications
    4.2 Global Cancer Tumor Profiling Sales Value by Application
        4.2.1 Global Cancer Tumor Profiling Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Cancer Tumor Profiling Sales Value, by Application (2020-2031)
        4.2.3 Global Cancer Tumor Profiling Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
    5.1 Global Cancer Tumor Profiling Sales Value by Region
        5.1.1 Global Cancer Tumor Profiling Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Cancer Tumor Profiling Sales Value by Region (2020-2025)
        5.1.3 Global Cancer Tumor Profiling Sales Value by Region (2026-2031)
        5.1.4 Global Cancer Tumor Profiling Sales Value by Region (%), (2020-2031)
    5.2 North America
        5.2.1 North America Cancer Tumor Profiling Sales Value, 2020-2031
        5.2.2 North America Cancer Tumor Profiling Sales Value by Country (%), 2024 VS 2031
    5.3 Europe
        5.3.1 Europe Cancer Tumor Profiling Sales Value, 2020-2031
        5.3.2 Europe Cancer Tumor Profiling Sales Value by Country (%), 2024 VS 2031
    5.4 Asia Pacific
        5.4.1 Asia Pacific Cancer Tumor Profiling Sales Value, 2020-2031
        5.4.2 Asia Pacific Cancer Tumor Profiling Sales Value by Region (%), 2024 VS 2031
    5.5 South America
        5.5.1 South America Cancer Tumor Profiling Sales Value, 2020-2031
        5.5.2 South America Cancer Tumor Profiling Sales Value by Country (%), 2024 VS 2031
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Cancer Tumor Profiling Sales Value, 2020-2031
        5.6.2 Middle East & Africa Cancer Tumor Profiling Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Cancer Tumor Profiling Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Cancer Tumor Profiling Sales Value, 2020-2031
    6.3 United States
        6.3.1 United States Cancer Tumor Profiling Sales Value, 2020-2031
        6.3.2 United States Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Cancer Tumor Profiling Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Cancer Tumor Profiling Sales Value, 2020-2031
        6.4.2 Europe Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Cancer Tumor Profiling Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Cancer Tumor Profiling Sales Value, 2020-2031
        6.5.2 China Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Cancer Tumor Profiling Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Cancer Tumor Profiling Sales Value, 2020-2031
        6.6.2 Japan Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Cancer Tumor Profiling Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Cancer Tumor Profiling Sales Value, 2020-2031
        6.7.2 South Korea Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Cancer Tumor Profiling Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Cancer Tumor Profiling Sales Value, 2020-2031
        6.8.2 Southeast Asia Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Cancer Tumor Profiling Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Cancer Tumor Profiling Sales Value, 2020-2031
        6.9.2 India Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Cancer Tumor Profiling Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 Qiagen N.V.
        7.1.1 Qiagen N.V. Profile
        7.1.2 Qiagen N.V. Main Business
        7.1.3 Qiagen N.V. Cancer Tumor Profiling Products, Services and Solutions
        7.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.1.5 Qiagen N.V. Recent Developments
    7.2 Roche Molecular Systems Inc.
        7.2.1 Roche Molecular Systems Inc. Profile
        7.2.2 Roche Molecular Systems Inc. Main Business
        7.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Products, Services and Solutions
        7.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.2.5 Roche Molecular Systems Inc. Recent Developments
    7.3 Abott Molecular
        7.3.1 Abott Molecular Profile
        7.3.2 Abott Molecular Main Business
        7.3.3 Abott Molecular Cancer Tumor Profiling Products, Services and Solutions
        7.3.4 Abott Molecular Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.3.5 Abott Molecular Recent Developments
    7.4 Illumina Inc.
        7.4.1 Illumina Inc. Profile
        7.4.2 Illumina Inc. Main Business
        7.4.3 Illumina Inc. Cancer Tumor Profiling Products, Services and Solutions
        7.4.4 Illumina Inc. Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.4.5 Illumina Inc. Recent Developments
    7.5 NeoGenomics Laboratories
        7.5.1 NeoGenomics Laboratories Profile
        7.5.2 NeoGenomics Laboratories Main Business
        7.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Products, Services and Solutions
        7.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.5.5 NeoGenomics Laboratories Recent Developments
    7.6 HTG Molecular Diagnostic
        7.6.1 HTG Molecular Diagnostic Profile
        7.6.2 HTG Molecular Diagnostic Main Business
        7.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Products, Services and Solutions
        7.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.6.5 HTG Molecular Diagnostic Recent Developments
    7.7 Genomic Health Inc.
        7.7.1 Genomic Health Inc. Profile
        7.7.2 Genomic Health Inc. Main Business
        7.7.3 Genomic Health Inc. Cancer Tumor Profiling Products, Services and Solutions
        7.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.7.5 Genomic Health Inc. Recent Developments
    7.8 Hologic Gen-Probe
        7.8.1 Hologic Gen-Probe Profile
        7.8.2 Hologic Gen-Probe Main Business
        7.8.3 Hologic Gen-Probe Cancer Tumor Profiling Products, Services and Solutions
        7.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.8.5 Hologic Gen-Probe Recent Developments
    7.9 BD Biosciences
        7.9.1 BD Biosciences Profile
        7.9.2 BD Biosciences Main Business
        7.9.3 BD Biosciences Cancer Tumor Profiling Products, Services and Solutions
        7.9.4 BD Biosciences Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.9.5 BD Biosciences Recent Developments
    7.10 Siemens Healthineers
        7.10.1 Siemens Healthineers Profile
        7.10.2 Siemens Healthineers Main Business
        7.10.3 Siemens Healthineers Cancer Tumor Profiling Products, Services and Solutions
        7.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.10.5 Siemens Healthineers Recent Developments
    7.11 Claris Life Sciences
        7.11.1 Claris Life Sciences Profile
        7.11.2 Claris Life Sciences Main Business
        7.11.3 Claris Life Sciences Cancer Tumor Profiling Products, Services and Solutions
        7.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.11.5 Claris Life Sciences Recent Developments
    7.12 Personal Genome Diagnostics, Inc.
        7.12.1 Personal Genome Diagnostics, Inc. Profile
        7.12.2 Personal Genome Diagnostics, Inc. Main Business
        7.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Products, Services and Solutions
        7.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.12.5 Personal Genome Diagnostics, Inc. Recent Developments
    7.13 Perthera, Inc.
        7.13.1 Perthera, Inc. Profile
        7.13.2 Perthera, Inc. Main Business
        7.13.3 Perthera, Inc. Cancer Tumor Profiling Products, Services and Solutions
        7.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.13.5 Perthera, Inc. Recent Developments
    7.14 Foundation Medicine, Inc
        7.14.1 Foundation Medicine, Inc Profile
        7.14.2 Foundation Medicine, Inc Main Business
        7.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Products, Services and Solutions
        7.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.14.5 Foundation Medicine, Inc Recent Developments
    7.15 V., Strand
        7.15.1 V., Strand Profile
        7.15.2 V., Strand Main Business
        7.15.3 V., Strand Cancer Tumor Profiling Products, Services and Solutions
        7.15.4 V., Strand Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.15.5 V., Strand Recent Developments
    7.16 ApoCell
        7.16.1 ApoCell Profile
        7.16.2 ApoCell Main Business
        7.16.3 ApoCell Cancer Tumor Profiling Products, Services and Solutions
        7.16.4 ApoCell Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.16.5 ApoCell Recent Developments
    7.17 Contextual Genomics
        7.17.1 Contextual Genomics Profile
        7.17.2 Contextual Genomics Main Business
        7.17.3 Contextual Genomics Cancer Tumor Profiling Products, Services and Solutions
        7.17.4 Contextual Genomics Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.17.5 Contextual Genomics Recent Developments
    7.18 Agendia
        7.18.1 Agendia Profile
        7.18.2 Agendia Main Business
        7.18.3 Agendia Cancer Tumor Profiling Products, Services and Solutions
        7.18.4 Agendia Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.18.5 Agendia Recent Developments
    7.19 GenScript
        7.19.1 GenScript Profile
        7.19.2 GenScript Main Business
        7.19.3 GenScript Cancer Tumor Profiling Products, Services and Solutions
        7.19.4 GenScript Cancer Tumor Profiling Revenue (US$ Million) & (2020-2025)
        7.19.5 GenScript Recent Developments

8 Industry Chain Analysis
    8.1 Cancer Tumor Profiling Industrial Chain
    8.2 Cancer Tumor Profiling Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Cancer Tumor Profiling Sales Model
        8.5.2 Sales Channel
        8.5.3 Cancer Tumor Profiling Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Cancer Tumor Profiling Market Trends
 Table 2. Cancer Tumor Profiling Market Drivers & Opportunity
 Table 3. Cancer Tumor Profiling Market Challenges
 Table 4. Cancer Tumor Profiling Market Restraints
 Table 5. Global Cancer Tumor Profiling Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Cancer Tumor Profiling Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Cancer Tumor Profiling Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Cancer Tumor Profiling Product Type
 Table 9. Key Companies Time to Begin Mass Production of Cancer Tumor Profiling
 Table 10. Global Cancer Tumor Profiling Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Cancer Tumor Profiling Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Cancer Tumor Profiling Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Cancer Tumor Profiling Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Cancer Tumor Profiling Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Cancer Tumor Profiling Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Cancer Tumor Profiling Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Cancer Tumor Profiling Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Cancer Tumor Profiling Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Cancer Tumor Profiling Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Cancer Tumor Profiling Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Cancer Tumor Profiling Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Cancer Tumor Profiling Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Cancer Tumor Profiling Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Cancer Tumor Profiling Sales Value by Region (2020-2025) & (%)
 Table 27. Global Cancer Tumor Profiling Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Cancer Tumor Profiling Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Cancer Tumor Profiling Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Cancer Tumor Profiling Sales Value, (2026-2031) & (US$ Million)
 Table 31. Qiagen N.V. Basic Information List
 Table 32. Qiagen N.V. Description and Business Overview
 Table 33. Qiagen N.V. Cancer Tumor Profiling Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Cancer Tumor Profiling Business of Qiagen N.V. (2020-2025)
 Table 35. Qiagen N.V. Recent Developments
 Table 36. Roche Molecular Systems Inc. Basic Information List
 Table 37. Roche Molecular Systems Inc. Description and Business Overview
 Table 38. Roche Molecular Systems Inc. Cancer Tumor Profiling Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Cancer Tumor Profiling Business of Roche Molecular Systems Inc. (2020-2025)
 Table 40. Roche Molecular Systems Inc. Recent Developments
 Table 41. Abott Molecular Basic Information List
 Table 42. Abott Molecular Description and Business Overview
 Table 43. Abott Molecular Cancer Tumor Profiling Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Cancer Tumor Profiling Business of Abott Molecular (2020-2025)
 Table 45. Abott Molecular Recent Developments
 Table 46. Illumina Inc. Basic Information List
 Table 47. Illumina Inc. Description and Business Overview
 Table 48. Illumina Inc. Cancer Tumor Profiling Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Cancer Tumor Profiling Business of Illumina Inc. (2020-2025)
 Table 50. Illumina Inc. Recent Developments
 Table 51. NeoGenomics Laboratories Basic Information List
 Table 52. NeoGenomics Laboratories Description and Business Overview
 Table 53. NeoGenomics Laboratories Cancer Tumor Profiling Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Cancer Tumor Profiling Business of NeoGenomics Laboratories (2020-2025)
 Table 55. NeoGenomics Laboratories Recent Developments
 Table 56. HTG Molecular Diagnostic Basic Information List
 Table 57. HTG Molecular Diagnostic Description and Business Overview
 Table 58. HTG Molecular Diagnostic Cancer Tumor Profiling Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Cancer Tumor Profiling Business of HTG Molecular Diagnostic (2020-2025)
 Table 60. HTG Molecular Diagnostic Recent Developments
 Table 61. Genomic Health Inc. Basic Information List
 Table 62. Genomic Health Inc. Description and Business Overview
 Table 63. Genomic Health Inc. Cancer Tumor Profiling Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Cancer Tumor Profiling Business of Genomic Health Inc. (2020-2025)
 Table 65. Genomic Health Inc. Recent Developments
 Table 66. Hologic Gen-Probe Basic Information List
 Table 67. Hologic Gen-Probe Description and Business Overview
 Table 68. Hologic Gen-Probe Cancer Tumor Profiling Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Cancer Tumor Profiling Business of Hologic Gen-Probe (2020-2025)
 Table 70. Hologic Gen-Probe Recent Developments
 Table 71. BD Biosciences Basic Information List
 Table 72. BD Biosciences Description and Business Overview
 Table 73. BD Biosciences Cancer Tumor Profiling Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Cancer Tumor Profiling Business of BD Biosciences (2020-2025)
 Table 75. BD Biosciences Recent Developments
 Table 76. Siemens Healthineers Basic Information List
 Table 77. Siemens Healthineers Description and Business Overview
 Table 78. Siemens Healthineers Cancer Tumor Profiling Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Cancer Tumor Profiling Business of Siemens Healthineers (2020-2025)
 Table 80. Siemens Healthineers Recent Developments
 Table 81. Claris Life Sciences Basic Information List
 Table 82. Claris Life Sciences Description and Business Overview
 Table 83. Claris Life Sciences Cancer Tumor Profiling Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Cancer Tumor Profiling Business of Claris Life Sciences (2020-2025)
 Table 85. Claris Life Sciences Recent Developments
 Table 86. Personal Genome Diagnostics, Inc. Basic Information List
 Table 87. Personal Genome Diagnostics, Inc. Description and Business Overview
 Table 88. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Cancer Tumor Profiling Business of Personal Genome Diagnostics, Inc. (2020-2025)
 Table 90. Personal Genome Diagnostics, Inc. Recent Developments
 Table 91. Perthera, Inc. Basic Information List
 Table 92. Perthera, Inc. Description and Business Overview
 Table 93. Perthera, Inc. Cancer Tumor Profiling Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Cancer Tumor Profiling Business of Perthera, Inc. (2020-2025)
 Table 95. Perthera, Inc. Recent Developments
 Table 96. Foundation Medicine, Inc Basic Information List
 Table 97. Foundation Medicine, Inc Description and Business Overview
 Table 98. Foundation Medicine, Inc Cancer Tumor Profiling Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Cancer Tumor Profiling Business of Foundation Medicine, Inc (2020-2025)
 Table 100. Foundation Medicine, Inc Recent Developments
 Table 101. V., Strand Basic Information List
 Table 102. V., Strand Description and Business Overview
 Table 103. V., Strand Cancer Tumor Profiling Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Cancer Tumor Profiling Business of V., Strand (2020-2025)
 Table 105. V., Strand Recent Developments
 Table 106. ApoCell Basic Information List
 Table 107. ApoCell Description and Business Overview
 Table 108. ApoCell Cancer Tumor Profiling Products, Services and Solutions
 Table 109. Revenue (US$ Million) in Cancer Tumor Profiling Business of ApoCell (2020-2025)
 Table 110. ApoCell Recent Developments
 Table 111. Contextual Genomics Basic Information List
 Table 112. Contextual Genomics Description and Business Overview
 Table 113. Contextual Genomics Cancer Tumor Profiling Products, Services and Solutions
 Table 114. Revenue (US$ Million) in Cancer Tumor Profiling Business of Contextual Genomics (2020-2025)
 Table 115. Contextual Genomics Recent Developments
 Table 116. Agendia Basic Information List
 Table 117. Agendia Description and Business Overview
 Table 118. Agendia Cancer Tumor Profiling Products, Services and Solutions
 Table 119. Revenue (US$ Million) in Cancer Tumor Profiling Business of Agendia (2020-2025)
 Table 120. Agendia Recent Developments
 Table 121. GenScript Basic Information List
 Table 122. GenScript Description and Business Overview
 Table 123. GenScript Cancer Tumor Profiling Products, Services and Solutions
 Table 124. Revenue (US$ Million) in Cancer Tumor Profiling Business of GenScript (2020-2025)
 Table 125. GenScript Recent Developments
 Table 126. Key Raw Materials Lists
 Table 127. Raw Materials Key Suppliers Lists
 Table 128. Cancer Tumor Profiling Downstream Customers
 Table 129. Cancer Tumor Profiling Distributors List
 Table 130. Research Programs/Design for This Report
 Table 131. Key Data Information from Secondary Sources
 Table 132. Key Data Information from Primary Sources
 Table 133. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Cancer Tumor Profiling Product Picture
 Figure 2. Global Cancer Tumor Profiling Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Cancer Tumor Profiling Sales Value (2020-2031) & (US$ Million)
 Figure 4. Cancer Tumor Profiling Report Years Considered
 Figure 5. Global Cancer Tumor Profiling Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cancer Tumor Profiling Revenue in 2024
 Figure 7. Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Next-generation Sequencing (NGS) Picture
 Figure 9. Polymerase Chain Reaction (PCR) Picture
 Figure 10. Immunohistochemistry (IHC) Picture
 Figure 11. In Situ Hybridization (ISH) Picture
 Figure 12. Microarray Picture
 Figure 13. Others Picture
 Figure 14. Global Cancer Tumor Profiling Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 15. Global Cancer Tumor Profiling Sales Value Market Share by Type, 2024 & 2031
 Figure 16. Product Picture of Personalized Medicine
 Figure 17. Product Picture of Diagnostics
 Figure 18. Product Picture of Biomarker Discovery
 Figure 19. Product Picture of Prognostics
 Figure 20. Product Picture of Research Applications
 Figure 21. Global Cancer Tumor Profiling Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 22. Global Cancer Tumor Profiling Sales Value Market Share by Application, 2024 & 2031
 Figure 23. North America Cancer Tumor Profiling Sales Value (2020-2031) & (US$ Million)
 Figure 24. North America Cancer Tumor Profiling Sales Value by Country (%), 2024 VS 2031
 Figure 25. Europe Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 26. Europe Cancer Tumor Profiling Sales Value by Country (%), 2024 VS 2031
 Figure 27. Asia Pacific Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 28. Asia Pacific Cancer Tumor Profiling Sales Value by Region (%), 2024 VS 2031
 Figure 29. South America Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 30. South America Cancer Tumor Profiling Sales Value by Country (%), 2024 VS 2031
 Figure 31. Middle East & Africa Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Middle East & Africa Cancer Tumor Profiling Sales Value by Country (%), 2024 VS 2031
 Figure 33. Key Countries/Regions Cancer Tumor Profiling Sales Value (%), (2020-2031)
 Figure 34. United States Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 35. United States Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
 Figure 36. United States Cancer Tumor Profiling Sales Value by Application (%), 2024 VS 2031
 Figure 37. Europe Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 38. Europe Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
 Figure 39. Europe Cancer Tumor Profiling Sales Value by Application (%), 2024 VS 2031
 Figure 40. China Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 41. China Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
 Figure 42. China Cancer Tumor Profiling Sales Value by Application (%), 2024 VS 2031
 Figure 43. Japan Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Japan Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
 Figure 45. Japan Cancer Tumor Profiling Sales Value by Application (%), 2024 VS 2031
 Figure 46. South Korea Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 47. South Korea Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
 Figure 48. South Korea Cancer Tumor Profiling Sales Value by Application (%), 2024 VS 2031
 Figure 49. Southeast Asia Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Southeast Asia Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
 Figure 51. Southeast Asia Cancer Tumor Profiling Sales Value by Application (%), 2024 VS 2031
 Figure 52. India Cancer Tumor Profiling Sales Value, (2020-2031) & (US$ Million)
 Figure 53. India Cancer Tumor Profiling Sales Value by Type (%), 2024 VS 2031
 Figure 54. India Cancer Tumor Profiling Sales Value by Application (%), 2024 VS 2031
 Figure 55. Cancer Tumor Profiling Industrial Chain
 Figure 56. Cancer Tumor Profiling Manufacturing Cost Structure
 Figure 57. Channels of Distribution (Direct Sales, and Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed

Related Reports

• 

  Global Cancer Tumor Profiling Market Research Report 2024

  Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.

  

  Published: 2024-01-16

  

  Pages: 95

  USD 2900.00

  (Single User License)

• 

  Cancer Tumor Profiling - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.

  

  Published: 2024-01-24

  

  Pages: 129

  USD 3950.00

  (Single User License)

• 

  Global Cancer Tumor Profiling Market Insights, Forecast to 2030

  Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.

  

  Published: 2024-04-12

  

  Pages: 116

  USD 4900.00

  (Single User License)

• 

  Global Cancer Tumor Profiling Market Research Report 2025

  The global market for Cancer Tumor Profiling was valued at US$ 49140 million in the year 2024 and is projected to reach a revised size of US$ 97300 million by 2031, growing at a CAGR of 10.4% during the forecast period.

  

  Published: 2025-02-27

  

  Pages: 95

  USD 2900.00

  (Single User License)

• 

  Global Cancer Tumor Profiling Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  The global Cancer Tumor Profiling market size was US$ 49140 million in 2024 and is forecast to a readjusted size of US$ 97300 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.

  

  Published: 2025-09-06

  

  Pages: 104

  USD 4250.00

  (Single User License)